Current and emerging therapies for acute myeloid leukemia
β Scribed by Tadeusz Robak; Agnieszka Wierzbowska
- Book ID
- 113544091
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 221 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0149-2918
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Crypt loss, pericapillary hemorrhage, and severe gastrointestinal graft-versus-host disease To the Editor: The very complete study of Melson et al. [1] demonstrates the value of crypt loss as a marker of severity in acute graft-versus-host disease (GVHD) in a series of colonic biopsies in twent
## Abstract Treatments for chronic myeloid leukemia (CML) represent a success story in molecular medicine. The development of imatinib, a tyrosine kinase inhibitor (TKI) targeted against the causative BcrβAbl oncoprotein in CML, has resulted in hematologic and cytogenetic remissions in all phases o